TGFB1 and neoplasm: TGF-β in the microenvironment also drives the conversion of cytotoxic NK cells (CD49a-CD49b+EOMES+) into ILC1 (CD49a+CD49b-EOMESint), which lose the ability to control the tumor growth (78).